Pacific Biosciences of Californ vs UnitedHealth Group Incorporated — Stock Comparison

PACB
Pacific Biosciences of Californ
$1.60
▲ 0.63%
vs
UNH
UnitedHealth Group Incorporated
$368.78
▼ 0.46%
Q·Score Winner
UnitedHealth Group Incorporated
UNH6.3/10vs 5.5/10

Q·Score Breakdown

5.5
Neutral
Overall
6.3
Neutral
3.4
Quality
6.2
5.7
Health
5.3
7.3
Growth
5.1
6.4
Valuation
7.3
5.2
Sentiment
8.1
PACB

Revenue expanding at 14% year-over-year.

low return on equity (-213%).

UNH

82% of 28 covering analysts have a positive rating.

limited growth momentum.

Analyst Consensus

HOLD
Target $2.38 (+48.4%)
6 analysts
BUY
Target $387.27 (+5.0%)
26 analysts

Fundamentals

PACB
UNH
Trailing P/E
27.9×
-3.8×
Forward P/E
17.8×
0.0%
Profit Margin
2.7%
34.3%
Gross Margin
18.8%
-213.5%
ROE
12.2%
13.8%
Revenue Growth
2.0%
Earnings Growth
0.7%
2.33
Beta
0.41
Price / Book
$497M
Market Cap
$334.9B
$1 – $3
52-Week Range
$235 – $410

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →